Research Articles | Page 2 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort descending Bone Marrow Disease
Quality of life and physicians' perception in myelodysplastic syndromes May 2012 Am J Blood Res myelodysplastic syndromes (MDS)
Costs and quality of life in patients with myelodysplastic syndromes. Aug 2013 Am J Blood Res myelodysplastic syndromes (MDS)
High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes Mar 2013 Am J Clin Pathol myelodysplastic syndromes (MDS)
Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival Dec 2014 Am J Clin Pathol myelodysplastic syndromes (MDS)
Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia Jun 2014 Am J Hematol aplastic anemia
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution Apr 2014 Am J Hematol myelodysplastic syndromes (MDS)
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Oct 2013 Am J Hematol aplastic anemia
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Oct 2013 Am J Hematol myelodysplastic syndromes (MDS)
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: A treatment versus no-treatment study Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)